Acquisition by Tomsche David Scott of 3172 shares of ImmuCell at 3.67 subject to Rule 16b-3
| ICCC Stock | USD 5.44 0.04 0.74% |
About 52% of ImmuCell's shareholders are presently thinking to get in. The analysis of overall sentiment of trading ImmuCell stock suggests that some investors are interested at this time. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
ImmuCell |
Filed transaction by ImmuCell Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
ImmuCell Fundamental Analysis
We analyze ImmuCell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmuCell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmuCell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
ImmuCell is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
ImmuCell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.
Peers
ImmuCell Related Equities
| TPST | Tempest Therapeutics | 5.56 | ||||
| LCTX | Lineage Cell | 5.00 | ||||
| HCWB | HCW Biologics | 3.85 | ||||
| ANEB | Anebulo Pharmaceuticals | 3.25 | ||||
| CVKD | Cadrenal Therapeutics, | 2.64 | ||||
| MNOV | MediciNova | 1.49 | ||||
| FENC | Fennec Pharmaceuticals | 1.24 | ||||
| ACOGF | Alpha Cognition | 0.94 | ||||
| RZLT | Rezolute | 0.77 | ||||
| LIPO | Lipella Pharmaceuticals | 0.37 | ||||
| XOMAO | XOMA | 0.12 | ||||
| TRGNF | Transgene | 0.00 | ||||
| ONTTF | Oxford Nanopore | 1.09 | ||||
| PTIX | Protagenic Therapeutics | 9.52 |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |